Ope, In Case You Missed It

Luminary Therapeutics selected as a 2022/2023 Showcase Company in NIH/NCI’s investor initiative program

  Luminary Therapeutics a clinical stage gamma delta allogeneic cellular therapy company. MINNEAPOLIS, MN, USA, July 19, 2022 /EINPresswire.com/ — Luminary Therapeutics was selected as a  investor initiative program. Luminary Therapeutics is a clinical stage allogeneic cellular therapy company. Its gamma delta expansion platform coupled with its non-viral cell engineering process is unique in the industry. Luminary Therapeutics’ novel ligand-based CAR designed to bind three targets is set to enter

SharpLink Gaming Sells to RSports Interactive

(Minneapolis, MN) — Jan. 23, 2024  — SharpLink Gaming Ltd. announced that on January 18, 2024, the Company entered into an agreement to sell all of the issued and outstanding shares of common stock or membership interests, as applicable, in its SportsHub/fantasy sports and free to play sports game development business units to RSports Interactive, Inc. (“RSports”) for $22.5 million in an all-cash transaction. Nearly all employees of these acquired